Pfizer's migraine pill becomes part of a risk-sharing trial
Pfizer’s migraine drug, Vydura/Nurtec (rimegepant), has until now been sold in Denmark for around DKK 200 to patients who have been prescribed the drug by their doctor.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.